Nov 27, 2019 - Global Blood's (GBT) Oxbryta wins the FDA nod to address sickle cell disease in patients aged 12 years and above. The approval comes three months ahead of schedule.
Nov 26, 2019 - There’s still a long way to go, but the newcomer is off to a good start.
Nov 26, 2019 - Here are four stocks that boast promising prospects and are most likely to be takeout targets.
Nov 25, 2019 - The FDA accepts Roche's (RHHBY) NDA for risdiplam under a priority review to treat spinal muscular atrophy. A verdict is pending on May 24, 2020.
Nov 25, 2019 - Novartis (NVS) set to acquire The Medicines Company and add a promising candidate to its cardiovascular pipeline.
Nov 25, 2019 - The Medicines Company (MDCO) agrees to the $85 per share or $9.7-billion acquisition offer from Novartis.
Nov 25, 2019 - A Day of Mergers: TIF, AMTD, MDCO & More
Nov 25, 2019 - While Tiffany's agrees to terms with French luxury brand LVMH, Schwab buys Ameritrade, Novartis takes Medicines Co. and more.
Nov 19, 2019 - Merck (MRK) and German partner Bayer's vericiguat reduces the risk of heart failure hospitalization or cardiovascular death in patients with worsening chronic heart failure.
Nov 19, 2019 - Aerie (AERI) will acquire Spanish ophthalmic pharmaceutical company, Avizorex Pharma, to add a mid-stage dry eye disease candidate to its pipeline.